Clinical characteristics and health status of spontaneous sputum producers in COPD

Dionne Braeken (Valkenburg a/d Geul, Netherlands), D.C.W. Braeken, S. Wilke, D.E. Smid, G.G.U. Rohde, J.J.C. Drijkoningen, E.F.M. Wouters, M.A. Spruit, F.M.E. Franssen

Source: International Congress 2015 – Best abstracts in chronic care
Session: Best abstracts in chronic care
Session type: Poster Discussion
Number: 3061
Disease area: Airway diseases

Congress or journal article abstract

Abstract

Background: Chronic sputum production occurs in a subset of COPD patients although its clinical relevance has not been established. Also, differences in symptoms, health status (HS) and other clinical outcomes between patients with and without positive sputum cultures are unknown.Objective: Compare clinical characteristics and HS of spontaneous sputum producers with a positive culture (SSP), a negative culture (SSN) and non-producers (NSS) in a cohort of COPD patients during pre-rehabilitation (PR) assessment.Methods: 518 stable COPD patients were comprehensively assessed before PR (55.6% males, age 64.1±9.1y, FEV₁ 48.6±20.0%pred). HS was measured with CAT, symptoms were assessed using a symptom checklist score and HADS. Differences between groups were investigated by univariate analysis and Post Hoc-test.Results: 31.7% of patients spontaneously produced sputum (n=164). Despite comparable lung function, SSP reported more frequent exacerbations than NSS. CAT scores were significantly higher in SSP compared to NSS. Sputum producers reported higher cough scores. HADS-D scores were significantly higher in SSP than NSS (table 1).



Conclusion: Chronic sputum production is common in COPD. Particularly patients with a positive culture have worse HS and more symptoms of cough and depression. Impact on disease progression and long-term outcomes remain to be established.Funding: Lung Foundation Netherlands (3.4.10.015) and GSK (SCO115406).


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Dionne Braeken (Valkenburg a/d Geul, Netherlands), D.C.W. Braeken, S. Wilke, D.E. Smid, G.G.U. Rohde, J.J.C. Drijkoningen, E.F.M. Wouters, M.A. Spruit, F.M.E. Franssen. Clinical characteristics and health status of spontaneous sputum producers in COPD. Eur Respir J 2015; 46: Suppl. 59, 3061

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact of lung function impairment and exacerbation history on COPD patient-reported utility
Source: International Congress 2014 – COPD markers
Year: 2014

The impact of exacerbations on adherence and outcomes of pulmonary rehabilitation in patients with COPD
Source: International Congress 2016 – Management of dyspnoea and exacerbations in chronic lung diseases
Year: 2016

Longitudinal changes in COPD patients in primary care
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016


Benefits of self-management education in COPD exacerbations
Source: International Congress 2015 – Best abstracts in chronic care
Year: 2015


Concordance between airway inflammation and health status in COPD patients with bacterial colonisation
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013


Repercussion of different physical therapy interventions on the perceived health status of AECOPD patients
Source: International Congress 2016 – Physiotherapy interventions and assessment options in hospitalised patients
Year: 2016


Change in the COPD assessment test (CAT) score as predictor of short-term evolution of patients admitted for an exacerbation of COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014

Short-term evaluation of a remote patient support program in patients with COPD and frequent exacerbations. ESOPO study
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015


The role of inflammatory biomarkers and health related quality of life questionnaires in distinction of exacerbation and stable chronic obstructive pulmonary diseases
Source: International Congress 2014 – Markers
Year: 2014


Effect of roflumilast on quality of life in frequent and infrequent exacerbators
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013


Impaired health status in primary care COPD patients is underestimated
Source: International Congress 2015 – Respiratory disease management in primary care
Year: 2015


Fatigue is related to decreased health status in COPD
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014

Examination of variations in responder rates in COPD clinical trial outcomes
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013

One-year change in health status and outcomes in chronic obstructive pulmonary disease
Source: International Congress 2014 – Best abstracts in chronic care
Year: 2014

Discordant symptom severity in COPD: The PHAROAH study
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015


Fatigue and limitation of daily activities as predictors of health status in COPD patients
Source: International Congress 2016 – Quality and quantity in lung function
Year: 2016

CAT-score is a predictor for mortality in COPD
Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Year: 2016


Association of asthma admissions and health related quality of life (HRQoL), asthma control and severity
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013


Integrated care reduces hospital utilization among patients with severe COPD
Source: International Congress 2014 – COPD exacerbations
Year: 2014

Comparison of CAT and mMRC in evaluating clinical symptoms co-morbidity and medical resource utilization in COPD patients
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014